Skip to main content

The Development of Medications for the Treatment of Opiate and Cocaine Addictions Issues for the Government and Private Sector (1995) / Chapter Skim
Currently Skimming:

Appendix A: Acknowledgments
Pages 201-206

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 201...
... Beary Pharmaceutical Research and Manufacturers of America 201 Martin Becker, Esq. New York, NY Walter Bell National Institute of Neurological Disorders and Stroke Leslie Benet University of California Shawn Bentley Senate Judiciary Committee Alex Bradford BioDevelopment Corporation Peter Bridge National Institute on Drug Abuse Bruce Burlington Food and Drug Administration
Read the entire page →
From page 202...
... Dieffenbach National Institute of Allergy and Infectious Diseases Herman Diesenhaus Substance Abuse and Mental Health Services Administration Christopher Doherty Fox, Bennett and Turner Jack Durell Treatment Research Institute Robert Eaton Pharmaceutical Manufacturers Association Barbara Espey Massachusetts Department of Public Health Susan Everingham RAND Rachel Feldman Lewin-VHI, Inc. Marian Fischman Columbia University
Read the entire page →
From page 203...
... Richard Hawks National Institute on Drug Abuse Rebecca Henderson Massachusetts Institute of Technology Carol Hubner National Institute on Drug Abuse James Isbister Pharmavene, Inc. David Joranson University of Wisconsin Medical School
Read the entire page →
From page 204...
... Martin, Jr. Du Pont Merck Pharmaceutical Company David McCann National Institute on Drug Abuse Mary Elizabeth McCaul Johns Hopkins University Hospital Howard McClain Drug Enforcement Administration Catherine McCormack Generic Pharmaceutical Industry Association Thomas McLellan Penn-VA Center for Studies of Addiction Daniel Melnick Substance Abuse and Mental Health Services Administration Richard Merrill University of Virginia School of Law Harry Meyer American Cyanamid Company
Read the entire page →
From page 205...
... Frank Sapienza Drug Enforcement Administration Alan Sartorelli Yale University School of Medicine Clifford Scharke National Institutes of Health Saul Schepartz National Cancer Institute David Schieser California Research Advisory Panel Sam Schildhaus Office of National Drug Control Policy Ian Shaffer Value Behavioral Health Dale Shoemaker National Cancer Institute
Read the entire page →
From page 206...
... 206 DEVELOPMENT OF MEDICATIONS Robert Sisko International Coalition for Addict Self Help Eve Slater Merck Research Laboratory Michael Smith Lincoln Hospital, New York Marvin Snyder National Institute on Drug Abuse Solomon Snyder Johns Hopkins University Steve Tabscot Texas Methadone Provider Group Robert Temple Food and Drug Administration John Thomas BioDevelopment Corporation Richard Thoreson Substance Abuse and Mental Health Services Administration Alan Trachtenberg National Institute on Drug Abuse Frank Vocci National Institute on Drug Abuse Jeane Van Lear Biotechnology Industry Organization William Vodra Arnold and Porter Ellen Weber Legal Action Center Bonnie Wilford George Washington University Curtis Wright Food and Drug Administration Paul Wohlford Substance Abuse and Mental Health Services Administration Thomas Wyatt National Association of State Controlled Substance Authorities Michael Young Proctor & Gamble
Read the entire page →

Key Terms

  • substance abuse
  • enforcement administration
  • drug enforcement
  • drug control
  • national drug

  • control policy
  • cancer institute
  • administration alan
  • merck research
  • neurological disorders

  • payte drug
  • dependence associates
  • judiciary committee
  • drug dependence
  • senate judiciary

  • biodevelopment corporation
  • association thomas
  • schieser california
  • sartorelli yale
  • institute david

  • rand barbara
  • abuse rebecca
  • shawn bentley
  • david schieser
  • mccaul johns

  • riddell rand
  • shaffer value
  • putala senate
  • roberts office
  • richard merrill


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.